TREX1, three prime repair exonuclease 1, 11277

N. diseases: 241; N. variants: 36
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0042373
Disease: Vascular Diseases
Vascular Diseases
0.050 Biomarker group BEFREE TREX1 immunohistochemistry demonstrated positivity in the nuclei of cells in the CNS and visceral organs, indicating aberrant localization of the truncated protein, and the expression was remarkable in oligodendrocytes within the lesion, suggesting possible involvement of the protein in the pathomechanism of vasculopathy leading to white matter degeneration. 30561700 2019
CUI: C0042373
Disease: Vascular Diseases
Vascular Diseases
0.050 GeneticVariation group BEFREE TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy. 25213617 2015
CUI: C0042373
Disease: Vascular Diseases
Vascular Diseases
0.050 GeneticVariation group BEFREE The identification of TREX1 mutations in families with retinal vasculopathy and associated diseases such as migraine may provide new insights in migraine pathophysiology. 18451712 2008
CUI: C0042373
Disease: Vascular Diseases
Vascular Diseases
0.050 GeneticVariation group BEFREE Mutations in TREX1 have been linked to a spectrum of human autoimmune diseases including Aicardi-Goutières syndrome (AGS), familial chilblain lupus (FCL), systemic lupus erythematosus, and retinal vasculopathy and cerebral leukodystrophy. 18805785 2008
CUI: C0042373
Disease: Vascular Diseases
Vascular Diseases
0.050 GeneticVariation group BEFREE C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. 17660820 2007